Randox Laboratories Ltd. has recalled approximately 59 units of its RX series Clinical Chemistry Analysers, including the Daytona Plus, Imola, Modena, and Monaco models. The recall was initiated because certain software settings for sample re-runs (specifically sample volume and dilution levels) may not work correctly when test results fall outside the normal assay range. This defect could cause the machines to produce and report incorrect medical data, which healthcare providers use for patient diagnosis and treatment decisions.
If the re-run feature malfunctions, the analyzer may report inaccurate patient test results. This poses a risk of medical misdiagnosis or delayed treatment, as clinicians rely on these specific laboratory measurements to evaluate a patient's health status.
Manufacturer corrective action regarding software settings.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.